Fannin UK has successfully completed the integration of Iskus Health UK, marking a significant expansion in its medical device and surgical solutions portfolio. The process received regulatory clearance from the Competition and Consumer Protection Commission, enabling full operational merger.

Established in 2012 as part of the Iskus Health Group, Iskus Health UK has earned trust as a supplier of high-quality medical and surgical devices, consumables, and sterile single-use products. The integration leverages Fannin UK’s established scale and logistics with Iskus’s deep clinical focus delivering enhanced patient safety, operational efficiency, and comprehensive care across the UK.

Key additions to Fannin’s offerings include:

• Kurin Jet blood culture collection system.
• Swash patient hygiene products.
• DryMax fluid-control floor mats.
• Tecnodrape Iodine surgical incise drapes.
• Primed tracheostomy and wound drainage items.
• Non-sterile clinical apparel, surgical draping, and procedure kits.

Leadership transitions highlight continuity: Stuart Murray, Iskus co-founder and former Commercial Director, steps into the role of Commercial Director for Fannin UK’s Surgical Division. With over 25 years in healthcare markets, Murray leads alongside the fully integrated Iskus sales team ensuring uninterrupted relationships and nationwide support.

Chris Soanes, Managing Director at Fannin UK, called it “a significant milestone enhancing our ability to provide comprehensive, reliable solutions to the UK healthcare sector.”

Customers gain from Fannin’s broader resources while retaining access to Iskus’s acclaimed products. Note: Iskus Health Ltd continues independently in Ireland (including Northern Ireland).

This integration positions Fannin UK as a stronger partner for healthcare providers, driving innovation and efficiency in medical devices amid evolving clinical needs.